A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
BeOne Medicines
BeOne Medicines
NiKang Therapeutics, Inc.
EMD Serono
AstraZeneca
Seagen Inc.
Eli Lilly and Company
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
AbbVie
Travera Inc
Iambic Therapeutics, Inc
National Cancer Institute (NCI)
Beijing Biotech
Jazz Pharmaceuticals
Bayer
Exscientia AI Limited
Alliance for Clinical Trials in Oncology
Conjupro Biotherapeutics, Inc.
Arcus Biosciences, Inc.
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Vanderbilt-Ingram Cancer Center
Sotio Biotech Inc.
SillaJen, Inc.
858 Therapeutics, Inc.
GlaxoSmithKline
SystImmune Inc.
Rondo Therapeutics
Institut Paoli-Calmettes
Seagen Inc.
AstraZeneca
University of Michigan Rogel Cancer Center
Psyence Australia Pty Ltd
Convalife (Shanghai) Co., Ltd.
University of California, Irvine
ViroMissile, Inc.
Yuhan Corporation
AstraZeneca
Tizona Therapeutics, Inc
Essen Biotech
Ulsan University Hospital
Brigham and Women's Hospital
Poseida Therapeutics, Inc.
Baylor College of Medicine
Abramson Cancer Center at Penn Medicine
MacroGenics
Nanjing Sanhome Pharmaceutical, Co., Ltd.
DualityBio Inc.
Daiichi Sankyo